Emergency treatment with levetiracetam or phenytoin in status epilepticus in children —the EcLiPSE study: study protocol for a randomised controlled trial

DiscussionThis clinical trial will determine whether phenytoin or levetiracetam is more effective as an intravenous second-line agent for CSE, and provide evidence for management recommendations. In addition, this trial will also provide data on which of these therapies is safer in this setting.Trial registrationISRCTN identifier,ISRCTN22567894. Registered on 27 August 2015EudraCT identifier,2014-002188-13. Registered on 21 May 2014NIHR HTA Grant:12/127/134
Source: Trials - Category: Research Source Type: clinical trials